AU2011226708B2 - Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders - Google Patents

Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders Download PDF

Info

Publication number
AU2011226708B2
AU2011226708B2 AU2011226708A AU2011226708A AU2011226708B2 AU 2011226708 B2 AU2011226708 B2 AU 2011226708B2 AU 2011226708 A AU2011226708 A AU 2011226708A AU 2011226708 A AU2011226708 A AU 2011226708A AU 2011226708 B2 AU2011226708 B2 AU 2011226708B2
Authority
AU
Australia
Prior art keywords
vfc
alginate
day
xanthan gum
glucomannan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011226708A
Other languages
English (en)
Other versions
AU2011226708A1 (en
Inventor
Roland J. Gahler
Christopher John Lawson
Michael Lyon
Simon Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inovobiologic Inc
Original Assignee
Inovobiologic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inovobiologic Inc filed Critical Inovobiologic Inc
Publication of AU2011226708A1 publication Critical patent/AU2011226708A1/en
Priority to AU2014213536A priority Critical patent/AU2014213536A1/en
Application granted granted Critical
Publication of AU2011226708B2 publication Critical patent/AU2011226708B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/27—Xanthan not combined with other microbial gums
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2011226708A 2010-03-10 2011-03-10 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders Active AU2011226708B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2014213536A AU2014213536A1 (en) 2010-03-10 2014-08-14 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US31263010P 2010-03-10 2010-03-10
US61/312,630 2010-03-10
US35765810P 2010-06-23 2010-06-23
US61/357,658 2010-06-23
PCT/CA2011/000260 WO2011109900A1 (en) 2010-03-10 2011-03-10 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2014213536A Division AU2014213536A1 (en) 2010-03-10 2014-08-14 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders

Publications (2)

Publication Number Publication Date
AU2011226708A1 AU2011226708A1 (en) 2012-09-27
AU2011226708B2 true AU2011226708B2 (en) 2015-04-02

Family

ID=44560211

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2011226708A Active AU2011226708B2 (en) 2010-03-10 2011-03-10 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders
AU2014213536A Abandoned AU2014213536A1 (en) 2010-03-10 2014-08-14 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2014213536A Abandoned AU2014213536A1 (en) 2010-03-10 2014-08-14 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders

Country Status (12)

Country Link
US (1) US20110223192A1 (https=)
EP (1) EP2544696B1 (https=)
JP (3) JP2013525269A (https=)
KR (1) KR20130039726A (https=)
CN (1) CN102892421A (https=)
AU (2) AU2011226708B2 (https=)
BR (1) BR112012022799B1 (https=)
CA (2) CA2859055A1 (https=)
NZ (1) NZ602249A (https=)
RU (1) RU2553348C2 (https=)
SG (1) SG183543A1 (https=)
WO (1) WO2011109900A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010039734A1 (de) * 2010-08-25 2012-03-01 Bayer Materialscience Aktiengesellschaft Katalysator und Verfahren zur Herstellung von Chlor durch Gasphasenoxidation
GB201110672D0 (en) * 2011-06-23 2011-08-10 M I Drilling Fluids Uk Ltd Wellbore fluid
TWI469785B (zh) * 2012-04-25 2015-01-21 Inovobiologic Inc 用於治療代謝性疾病之膳食纖維組成物
US9386790B2 (en) 2013-07-01 2016-07-12 University Of Southern California Fasting condition as dietary treatment of diabetes
CN104277130A (zh) 2013-07-02 2015-01-14 中国科学院上海药物研究所 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途
CN103604884B (zh) * 2013-11-21 2015-10-28 南京工业大学 一种检测海藻生物质内还原性糖类物质的方法
JP2017501158A (ja) * 2013-12-18 2017-01-12 ティラビスコ アーベー 嗜好性食品に対する衝動を減らすためのチラコイドの使用
KR20160001935A (ko) 2014-06-30 2016-01-07 원광대학교산학협력단 블랙 커런트 추출물을 유효성분으로 함유하는 대사증후군의 예방, 개선 또는 치료를 위한 조성물
CN104391049B (zh) * 2014-09-20 2017-03-22 鄂尔多斯市中轩生化股份有限公司 黄原胶微量溶剂残留量的检测方法
SMT202300091T1 (it) * 2014-11-26 2023-05-12 Omega Pharma Innovation And Dev Nv Composizione di fibre dietetica
EP3862002A1 (en) * 2015-01-26 2021-08-11 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
CN108463121A (zh) * 2016-01-12 2018-08-28 南加利福尼亚大学 长期禁食模仿作为多发性骨髓瘤和其它癌症的膳食治疗的用途
US10485253B2 (en) 2017-08-21 2019-11-26 Mustapha Benmoussa Method of microalgal biomass processing for high-value chemicals production, the resulting composition of butyrogenic algal slowly fermenting dietary fiber, and a way to improve colon health using a slowly fermenting butyrogenic algal dietary fiber
BR112021000917B1 (pt) 2018-07-23 2023-12-26 Nutragenom, Llc Solução de glucomanano e composição de geração de h2
CN110412157A (zh) * 2019-07-17 2019-11-05 广州金评检测研究院有限公司 一种烟酰胺原料中烟酸的测定方法
JP7412759B2 (ja) * 2020-04-16 2024-01-15 松谷化学工業株式会社 水溶性食物繊維のエネルギー量の簡便な測定方法
CN112933105A (zh) * 2021-02-10 2021-06-11 浙江工业大学 甘露葡萄糖醛酸多（寡）糖及硫酸化衍生物在制备治疗非酒精性脂肪肝药物中的应用
CN112782321A (zh) * 2021-03-09 2021-05-11 上海市质量监督检验技术研究院 一种快速检测纺织品中维生素e含量的测定方法
CN117665192A (zh) * 2023-06-30 2024-03-08 辰欣药业股份有限公司 一种特殊医学用途全营养配方乳剂食品中钾、钙、钠、镁的测定方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049401A (en) * 1989-03-17 1991-09-17 Uni Colloid Kabushiki Kaisha Glucomannan product and a method to coagulate it
US5460957A (en) * 1992-04-28 1995-10-24 Maruha Corporation Calcium alginate oligosaccharide and method for producing the same from potassium or sodium alginate
CA2560224A1 (en) * 2004-03-17 2005-09-29 Chiron Srl Analysis of saccharide vaccines without interference
US20060228397A1 (en) * 2005-04-12 2006-10-12 Natural Factors Nutritional Products Ltd. Dietary supplement, and methods of use
US20080027024A1 (en) * 2005-04-12 2008-01-31 Natural Factors Nutritional Products Ltd. Dietary supplement and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0683118B2 (ja) * 1988-01-19 1994-10-19 日本電気株式会社 直流終端回路
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049401A (en) * 1989-03-17 1991-09-17 Uni Colloid Kabushiki Kaisha Glucomannan product and a method to coagulate it
US5460957A (en) * 1992-04-28 1995-10-24 Maruha Corporation Calcium alginate oligosaccharide and method for producing the same from potassium or sodium alginate
CA2560224A1 (en) * 2004-03-17 2005-09-29 Chiron Srl Analysis of saccharide vaccines without interference
US20060228397A1 (en) * 2005-04-12 2006-10-12 Natural Factors Nutritional Products Ltd. Dietary supplement, and methods of use
US20080027024A1 (en) * 2005-04-12 2008-01-31 Natural Factors Nutritional Products Ltd. Dietary supplement and methods of use

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BURANA-OSOT, J ET AL (2010) Carbohydrate Polymers 81: 461-465 *
CARABIN, IG et al (2009) Nutrition Journal 8: 9 *
DALLIES, N ET AL (1998) Yeast 14: 1297-1306 *
GARNA, H et al (2004) J Agric Food Chem 52: 4652-4659 *
JENKINS, A et al (2009) The FASEB Journal 22: 305-307 *
KRULL, LH & COTE, GL (1992) Carbohydrate Polymers 17: 205-207 *
MANCA, MC ET AL (1996) Applied and Environmental Microbiology 62: 3265-3269 *
SONESSON, A ET AL (1994) Microbiology 140: 1261-1271 *
YU IP, CC ET AL (1992) Analytical Biochemistry 201: 343-349 *

Also Published As

Publication number Publication date
JP2013525269A (ja) 2013-06-20
EP2544696A1 (en) 2013-01-16
EP2544696B1 (en) 2019-05-22
RU2012142237A (ru) 2014-04-20
EP2544696A4 (en) 2013-08-21
KR20130039726A (ko) 2013-04-22
CA2859055A1 (en) 2011-09-15
US20110223192A1 (en) 2011-09-15
JP2015083604A (ja) 2015-04-30
RU2553348C2 (ru) 2015-06-10
JP2017074072A (ja) 2017-04-20
CN102892421A (zh) 2013-01-23
BR112012022799B1 (pt) 2021-11-30
CA2791418C (en) 2016-07-05
AU2014213536A1 (en) 2014-09-04
CA2791418A1 (en) 2011-09-15
BR112012022799A2 (pt) 2021-03-23
AU2011226708A1 (en) 2012-09-27
NZ602249A (en) 2014-10-31
SG183543A1 (en) 2012-10-30
WO2011109900A1 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
AU2011226708B2 (en) Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders
Liu et al. The physicochemical properties, in vitro binding capacities and in vivo hypocholesterolemic activity of soluble dietary fiber extracted from soy hulls
Capuano The behavior of dietary fiber in the gastrointestinal tract determines its physiological effect
Panahi et al. β-Glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity
Lovegrove et al. Role of polysaccharides in food, digestion, and health
Rose et al. Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern
Roberfroid Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects
Coudray et al. Effect of soluble or partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men
Hardacre et al. The effect of fibre and gelatinised starch type on amylolysis and apparent viscosity during in vitro digestion at a physiological shear rate
CA2967284C (en) A dietary fibre composition
Guo et al. The hydration rate of konjac glucomannan after consumption affects its in vivo glycemic response and appetite sensation and in vitro digestion characteristics
NZ583396A (en) Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
Yang et al. Effect of complexation with different molecular weights of oat β-glucan and sea buckthorn flavonoid on the digestion of rice flour
Liu et al. Effects of pectins and sugars on β-carotene bioaccessibility in an in vitro simulated digestion model
CN101622032A (zh) 预防或治疗代谢综合征的方法
TWI630875B (zh) 用於延遲代謝症候群之發作及／或降低代謝症候群之嚴重性的方法
Parolini Effects of fibers and gut microbiota on low-grade inflammatory human disease
Khramova et al. Psyllium‐enriched mashed potatoes: impact of texture, rheology, and oral processing on starch digestion
Thibault et al. Sugar beet fiber: production, composition, physicochemical properties, physiological effects, safety, and food applications
AU2014262248B2 (en) Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
Yamatoya et al. Effects of xyloglucan on lipid metabolism
Srinivasan Cluster beans
Ralet et al. Sugar beet fiber: Production, characteristics, food applications, and physiological benefits
Rose et al. Overview of dietary fiber and its influence on gastrointestinal health
Lyon Dietary Fiber

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)